Infliximab in patients with systemic vasculitis that is difficult to treat: poor outcome and significant adverse effects.
about
Infliximab in patients with systemic vasculitis that is difficult to treat: poor outcome and significant adverse effects.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Infliximab in patients with sy ...... d significant adverse effects.
@en
Infliximab in patients with sy ...... d significant adverse effects.
@nl
type
label
Infliximab in patients with sy ...... d significant adverse effects.
@en
Infliximab in patients with sy ...... d significant adverse effects.
@nl
prefLabel
Infliximab in patients with sy ...... d significant adverse effects.
@en
Infliximab in patients with sy ...... d significant adverse effects.
@nl
P2860
P356
P1476
Infliximab in patients with sy ...... d significant adverse effects.
@en
P2093
David P D'Cruz
Shirish R Sangle
P2860
P304
P356
10.1136/ARD.2006.065623
P407
P577
2007-04-01T00:00:00Z